Page 2 - Chimerix Plunges News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chimerix plunges. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chimerix Plunges Today - Breaking & Trending Today

Chimerix (NASDAQ:CMRX) Stock Price Crosses Below 200 Day Moving Average of $1.17

Chimerix, Inc. (NASDAQ:CMRX – Get Free Report)’s share price passed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $1.17 and traded as low as $0.97. Chimerix shares last traded at $0.98, with a volume of 403,193 shares changing hands. Analysts Set […] ....

Dimensional Fund Advisors , Chimerix Company Profile , Swiss National Bank , Jpmorgan Chase Co , Chimerix Inc , Metlife Investment Management , Get Free Report , National Bank , Life Investment Management , Fund Advisors , Cetera Investment Advisers , Chimerix Daily , Nasdaq Cmrx ,

Chimerix (NASDAQ:CMRX) Coverage Initiated at StockNews.com

StockNews.com started coverage on shares of Chimerix (NASDAQ:CMRX – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Other analysts have also issued reports about the stock. Robert W. Baird began coverage on shares of Chimerix in a research report on Monday, May 22nd. They […] ....

Robertw Baird , Metlife Investment Management , Chimerix Inc , Swiss National Bank , Dimensional Fund Advisors , Jpmorgan Chase Co , Chimerix Company Profile , Free Report , Moderate Buy , National Bank , Life Investment Management , Fund Advisors , Cetera Investment Advisers , Get Free Report , Chimerix Daily , Nasdaq Cmrx , Initiated Coverage , Stocknews Com ,

Chimerix (NASDAQ:CMRX) Given Buy Rating at HC Wainwright

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “buy” rating reaffirmed by equities researchers at HC Wainwright in a research note issued to investors on Wednesday, Benzinga reports. They currently have a $11.00 target price on the biopharmaceutical company’s stock. A number of other brokerages have also recently commented on CMRX. Robert W. Baird […] ....

Robertw Baird , Michaelt Andriole , Armistice Capital , Chimerix Inc , Vanguard Group Inc , Renaissance Technologies , Chimerix Company Profile , Get Free Report , Street Corp , Asset Management , Chimerix Daily , Nasdaq Cmrx , Reiterated Rating , Hc Wainwright ,

Wedbush Reiterates "Outperform" Rating for Chimerix (NASDAQ:CMRX)

Chimerix (NASDAQ:CMRX – Get Free Report)‘s stock had its “outperform” rating reaffirmed by analysts at Wedbush in a research report issued to clients and investors on Wednesday, RTT News reports. They currently have a $6.00 price objective on the biopharmaceutical company’s stock. CMRX has been the topic of several other research reports. Robert W. Baird […] ....

Michaelt Andriole , Robertw Baird , Securities Exchange Commission , Principal Financial Group Inc , Chimerix Company Profile , Pricet Rowe Associates Inc , Schonfeld Strategic Advisors , Chimerix Inc , Get Free Report , Exchange Commission , Strategic Advisors , Principal Financial Group , Financial Group , Chimerix Daily , Nasdaq Cmrx , Reiterated Rating ,

HC Wainwright Reaffirms "Buy" Rating for Chimerix (NASDAQ:CMRX)

HC Wainwright reaffirmed their buy rating on shares of Chimerix (NASDAQ:CMRX – Free Report) in a research report report published on Friday morning, Benzinga reports. The brokerage currently has a $11.00 target price on the biopharmaceutical company’s stock. Other analysts have also recently issued reports about the company. StockNews.com started coverage on Chimerix in a […] ....

Michaelt Andriole , Robertw Baird , Sg Americas Securities , Chimerix Inc , Bailard Inc , Pricet Rowe Associates Inc , Principal Financial Group Inc , Free Report , Trading Down , Financial Group , Engineers Gate Manager , Get Free Report , Chimerix Daily , Nasdaq Cmrx , Reiterated Rating , Hc Wainwright ,